Integrated bioinformatics analysis identifies established and novel TGFβ1-regulated genes modulated by anti-fibrotic drugs
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Integrated bioinformatics analysis identifies established and novel TGFβ1-regulated genes modulated by anti-fibrotic drugs ; volume:12 ; number:1 ; day:23 ; month:2 ; year:2022 ; pages:1-9 ; date:12.2022
Scientific reports ; 12, Heft 1 (23.2.2022), 1-9, 12.2022
- Urheber
-
Wilson, Ava C.
Chiles, Joe
Ashish, Shah
Chanda, Diptiman
Kumar, Preeti L.
Mobley, James A.
Neptune, Enid R.
Thannickal, Victor J.
McDonald, Merry-Lynn N.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-07151-1
- URN
-
urn:nbn:de:101:1-2022120621421532662133
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
12.06.2025, 01:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wilson, Ava C.
- Chiles, Joe
- Ashish, Shah
- Chanda, Diptiman
- Kumar, Preeti L.
- Mobley, James A.
- Neptune, Enid R.
- Thannickal, Victor J.
- McDonald, Merry-Lynn N.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Adhesive anti-fibrotic interfaces on diverse organs
Anti-fibrotic potential of erythropoietin signaling on bone marrow derived fibrotic cell
Anti-fibrotic effects of phenolic compounds on pancreatic stellate cells
Identification and functional characterization of anti-fibrotic natural compounds in vitro
Anti-Fibrotic Activity of an Antimicrobial Peptide in a Drosophila Model
Cell mediated ECM-degradation as an emerging tool for anti-fibrotic strategy
Anti-fibrotic action of pirfenidone in Dupuytren’s disease-derived fibroblasts
The multi-modal effect of the anti-fibrotic drug pirfenidone on NSCLC
Anti-fibrotic effect of a selective estrogen receptor modulator in systemic sclerosis
Hepatoprotective and Anti-fibrotic Agents: Its Time to Take the Next Step
Development and characterization of anti-fibrotic natural compound similars with improved effectivity
Anti-inflammatory and anti-fibrotic effects of berberine-loaded liquid crystalline nanoparticles
Adhesive anti-fibrotic interfaces on diverse organs
Anti-fibrotic potential of erythropoietin signaling on bone marrow derived fibrotic cell
Anti-fibrotic effects of phenolic compounds on pancreatic stellate cells
Identification and functional characterization of anti-fibrotic natural compounds in vitro
Anti-Fibrotic Activity of an Antimicrobial Peptide in a Drosophila Model
Cell mediated ECM-degradation as an emerging tool for anti-fibrotic strategy
Anti-fibrotic action of pirfenidone in Dupuytren’s disease-derived fibroblasts
The multi-modal effect of the anti-fibrotic drug pirfenidone on NSCLC
Anti-fibrotic effect of a selective estrogen receptor modulator in systemic sclerosis
Hepatoprotective and Anti-fibrotic Agents: Its Time to Take the Next Step
Development and characterization of anti-fibrotic natural compound similars with improved effectivity
Anti-inflammatory and anti-fibrotic effects of berberine-loaded liquid crystalline nanoparticles
Adhesive anti-fibrotic interfaces on diverse organs
Anti-fibrotic potential of erythropoietin signaling on bone marrow derived fibrotic cell
Anti-fibrotic effects of phenolic compounds on pancreatic stellate cells
Identification and functional characterization of anti-fibrotic natural compounds in vitro
Anti-Fibrotic Activity of an Antimicrobial Peptide in a Drosophila Model
Cell mediated ECM-degradation as an emerging tool for anti-fibrotic strategy
Anti-fibrotic action of pirfenidone in Dupuytren’s disease-derived fibroblasts
The multi-modal effect of the anti-fibrotic drug pirfenidone on NSCLC
Anti-fibrotic effect of a selective estrogen receptor modulator in systemic sclerosis
Hepatoprotective and Anti-fibrotic Agents: Its Time to Take the Next Step
Development and characterization of anti-fibrotic natural compound similars with improved effectivity